3/22/2011 8:29:31 AM
HOUSTON--(BUSINESS WIRE)--Emerging Healthcare Solutions (PinkSheets:EHSI) personnel began training on Monday to use the company’s NASA-developed bioreactor to conduct stem cell research. Last December, EHSI acquired a sub-license from Houston-based biotech firm Regenetech for the NASA developed rotating-wall bioreactor. Originally designed to facilitate the growth of human stem cells in simulated weightlessness, the bioreactor is key to EHSI’s mission to develop the Rutherford Procedure, a groundbreaking new proton therapy treatment for liver disease. Medically trained EHSI personnel traveled to Regentech’s stem-cell laboratory near Johnson Space Center on Monday to begin learning to use the high-tech device.
comments powered by